Valuation: Sun Pharmaceutical Industries Ltd.

Market Cap 4,48700Cr 4.8TCr 4.36TCr 4.03TCr 3.63TCr 6.86TCr 7.12TCr 49TCr 19TCr 2,42100Cr 18TCr 18TCr 7,64900Cr P/E 2027 *
36.5x
P/E 2028 * 30x
Enterprise Value 4,19100Cr 4.49TCr 4.07TCr 3.76TCr 3.39TCr 6.41TCr 6.65TCr 45TCr 18TCr 2,26100Cr 17TCr 16TCr 7,14500Cr EV / Sales 2027 *
6.47x
EV / Sales 2028 * 5.7x
Free-Float
44.39%
Yield 2027 *
0.88%
Yield 2028 * 1.05%
1 day+0.13%
1 week-1.81%
Current month+5.19%
1 month+6.32%
3 months-0.64%
6 months-0.44%
Current year+8.74%
1 week 1,856.8
Extreme 1856.8
1,915
1 month 1,719.1
Extreme 1719.1
1,943.9
Current year 1,583.7
Extreme 1583.7
2,046.9
1 year 1,583.7
Extreme 1583.7
2,046.9
3 years 1,184.5
Extreme 1184.5
2,046.9
5 years 733.7
Extreme 733.7
2,046.9
10 years 312
Extreme 312
2,046.9
Manager TitleAgeSince
Chief Executive Officer 59 01/09/2025
Chief Executive Officer - -
Director of Finance/CFO 58 01/07/2025
Director TitleAgeSince
Chairman 70 -
Director/Board Member 59 01/09/2025
Director/Board Member 71 21/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%-1.81%+6.02%+56.54% 4.77TCr
-1.13%-1.17%+38.55%+139.23% 1,27500Cr
-1.36%-0.74%+39.64%+86.06% 68TCr
-0.59%-0.36%+25.14%+111.73% 52TCr
-0.76%+1.10%+41.43%+70.96% 39TCr
-0.75%-3.16%+54.39%+40.90% 36TCr
-1.83%-0.89%+26.00%+58.48% 31TCr
-1.65%-0.59%+1.55%+34.52% 29TCr
-0.95%-1.57%+34.01%+72.55% 25TCr
+1.60%-0.36%+37.21%+125.66% 21TCr
Average -0.73%-0.52%+30.39%+79.66% 43TCr
Weighted average by Cap. -0.96%-0.56%+34.64%+95.19%

Financials

2027 *2028 *
Net sales 65TCr 693.61Cr 629.66Cr 581.65Cr 524.74Cr 990.63Cr 1.03TCr 7.01TCr 2.77TCr 35TCr 2.6TCr 2.55TCr 1,10500Cr 72TCr 774.19Cr 702.81Cr 649.23Cr 585.7Cr 1.11TCr 1.15TCr 7.82TCr 3.09TCr 39TCr 2.9TCr 2.84TCr 1,23300Cr
Net income 12TCr 129.25Cr 117.33Cr 108.39Cr 98Cr 184.6Cr 191.66Cr 1.31TCr 516.57Cr 6.52TCr 484.93Cr 474.72Cr 21TCr 15TCr 160.71Cr 145.9Cr 134.77Cr 121.59Cr 229.54Cr 238.32Cr 1.62TCr 642.33Cr 8.1TCr 602.98Cr 590.29Cr 26TCr
Net Debt -30TCr -316.78Cr -287.57Cr -265.65Cr -239.65Cr -452.43Cr -469.75Cr -3.2TCr -1.27TCr -16TCr -1.19TCr -1.16TCr -50TCr -37TCr -392.23Cr -356.07Cr -328.92Cr -296.73Cr -560.19Cr -581.64Cr -3.96TCr -1.57TCr -20TCr -1.47TCr -1.44TCr -62TCr
Projected Income Statement - Annual - Sun Pharmaceutical Industries Ltd.
Logo Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Employees
47,000
Date Price Change Volume
17/26/17 ₹1,870.00 +0.13% 14,38,065
16/26/16 ₹1,867.50 -0.66% 13,01,410
13/26/13 ₹1,880.00 -0.27% 20,37,762
12/26/12 ₹1,885.00 -0.91% 24,64,003
11/26/11 ₹1,902.30 -0.12% 22,62,492
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Sun Pharmaceutical Industries Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
1,870.00INR
Average target price
2,111.94INR
Spread / Average Target
+12.94%
  1. Stock Market
  2. Stocks
  3. SUNPHARMA Stock